These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 28558744

  • 1. Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever.
    Ugurlu S, Hacioglu A, Adibnia Y, Hamuryudan V, Ozdogan H.
    Orphanet J Rare Dis; 2017 May 30; 12(1):105. PubMed ID: 28558744
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
    Varan Ö, Kucuk H, Babaoglu H, Guven SC, Ozturk MA, Haznedaroglu S, Goker B, Tufan A.
    Mod Rheumatol; 2019 Mar 30; 29(2):363-366. PubMed ID: 29578360
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever.
    Hamanoue S, Suwabe T, Hoshino J, Sumida K, Mise K, Hayami N, Sawa N, Takaichi K, Fujii T, Ohashi K, Yazaki M, Ikeda S, Ubara Y.
    Mod Rheumatol; 2016 Jul 30; 26(4):610-3. PubMed ID: 25619282
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The assessment of tocilizumab therapy on recurrent attacks of patients with familial Mediterranean fever: A retrospective study of 15 patients.
    Colak S, Tekgoz E, Cinar M, Yilmaz S.
    Mod Rheumatol; 2021 Jan 30; 31(1):223-225. PubMed ID: 31903820
    [Abstract] [Full Text] [Related]

  • 6. AA amyloidosis treated with tocilizumab: case series and updated literature review.
    Courties A, Grateau G, Philippe P, Flipo RM, Astudillo L, Aubry-Rozier B, Fabreguet I, Fahd W, Fain O, Guggenbuhl P, Hachulla E, Papo T, Richez C, Sibilia J, Morel J, Berenbaum F, Sellam J, Club Rhumatismes Inflammation and the REGATE Registry.
    Amyloid; 2015 Jan 30; 22(2):84-92. PubMed ID: 25585627
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever.
    Ugurlu S, Ergezen B, Egeli BH, Selvi O, Ozdogan H.
    Rheumatology (Oxford); 2020 Dec 01; 59(12):3892-3899. PubMed ID: 32556219
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Atypical Familial Mediterranean Fever Complicated with Gastrointestinal Amyloidosis Diagnosed due to Paroxysmal Arthralgia and Intractable Diarrhea, Successfully Treated with Tocilizumab.
    Aikawa E, Shimizu T, Koga T, Endo Y, Umeda M, Hori T, Irie J, Kuroda K, Eguchi M, Okamoto M, Tsuji S, Takatani A, Igawa T, Sumiyoshi R, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.
    Intern Med; 2019 Jun 15; 58(12):1781-1785. PubMed ID: 30713308
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience.
    Abedi AS, Nakhjavani JM, Etemadi J.
    Transplant Proc; 2013 Jun 15; 45(10):3502-4. PubMed ID: 24314942
    [Abstract] [Full Text] [Related]

  • 14. Successful treatment of nephrotic syndrome due to FMF amyloidosis with azathioprine: report of three Turkish cases.
    Sayarlioglu H, Erkoc R, Sayarlioglu M, Dogan E, Soyoral Y.
    Rheumatol Int; 2006 Dec 15; 27(2):197-9. PubMed ID: 16944160
    [Abstract] [Full Text] [Related]

  • 15. Could tocilizumab be used in familial Mediterranean Fever? A systematic review.
    Mertz P, Hentgen V, Georgin-Lavialle S.
    Rheumatology (Oxford); 2024 Jul 01. PubMed ID: 38950176
    [Abstract] [Full Text] [Related]

  • 16. Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.
    Bilgen SA, Kilic L, Akdogan A, Kiraz S, Kalyoncu U, Karadag O, Ertenli I, Dogan I, Calguneri M.
    J Clin Rheumatol; 2011 Oct 01; 17(7):358-62. PubMed ID: 21946459
    [Abstract] [Full Text] [Related]

  • 17. Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome.
    Livneh A, Zemer D, Langevitz P, Laor A, Sohar E, Pras M.
    Arthritis Rheum; 1994 Dec 01; 37(12):1804-11. PubMed ID: 7986228
    [Abstract] [Full Text] [Related]

  • 18. Amyloidosis and Glomerular Diseases in Familial Mediterranean Fever.
    Siligato R, Gembillo G, Calabrese V, Conti G, Santoro D.
    Medicina (Kaunas); 2021 Oct 01; 57(10):. PubMed ID: 34684086
    [Abstract] [Full Text] [Related]

  • 19. Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis.
    Özçakar ZB, Özdel S, Yılmaz S, Kurt-Şükür ED, Ekim M, Yalçınkaya F.
    Clin Rheumatol; 2016 Feb 01; 35(2):441-6. PubMed ID: 25213327
    [Abstract] [Full Text] [Related]

  • 20. [Familial Mediterranean Fever (FMF): from diagnosis to treatment].
    Medlej-Hashim M, Loiselet J, Lefranc G, Mégarbané A.
    Sante; 2004 Feb 01; 14(4):261-6. PubMed ID: 15745878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.